Results 161 to 170 of about 679,715 (383)
An Imaging Gas Scintillation Proportional Counter for the Detection of Subkiloelectron-Volt X-Rays [PDF]
C.J. Hailey+2 more
openalex +1 more source
Ames collaborative study of cosmic ray neutrons [PDF]
The results of a collaborative study to define both the neutron flux and the spectrum more precisely and to develop a dosimetry package that can be flown quickly to altitude for solar flare events are described.
Baum, J. W.+9 more
core +1 more source
Enhanced multicolor persistent luminescence with optimized trap depths (≈0.73 eV) in Ca3Ga2Ge3O12:Pr3+ phosphors enable advanced anti‐counterfeiting, optical storage, and high‐resolution X‐ray imaging (4 lp mm−1), surpassing commercial screens.
Annu Balhara+8 more
wiley +1 more source
CALCULATION OF THE PULSE-HEIGHT RESPONSE OF NaI(Tl) SCINTILLATION COUNTERS
C. D. Zerby, H.S. Moran
openalex +2 more sources
A Radiocarbon Dating Protocol for use with Packard Scintillation Counters Employing Burst-Counting Circuitry [PDF]
G T Cook, Robert F. Anderson
openalex +1 more source
N. Horvatinčič+3 more
semanticscholar +1 more source
Combining multiple anti‐tumor therapeutic modalities using nanoparticles allows harnessing their therapeutic potential in combination with minimal side effects at lower doses. This study focuses on the development of tumor‐responsive core‐shell glyconanoparticle formulation targeting galectin‐3 in triple‐negative breast cancer (TNBC) for Auger ...
Shishu Kant Suman+3 more
wiley +1 more source
IBM-704 CODES FOR PREDICTING THE RESPONSE OF GAMMA-RAY SCINTILLATION COUNTERS
C. D. Zerby, H.S. Moran
openalex +2 more sources
Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants. [PDF]
Abstract Aims Paltusotine is a novel, nonpeptide, selective somatostatin receptor 2 agonist in development for the treatment of acromegaly and carcinoid syndrome. This study investigated the mass balance, routes of excretion, absolute bioavailability and metabolite profile of orally administered paltusotine.
Luo R+6 more
europepmc +2 more sources